These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16447195)

  • 1. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis.
    Zheng S; Chen Y; Liang T; Lu A; Wang W; Shen Y; Zhang M
    Liver Transpl; 2006 Feb; 12(2):253-8. PubMed ID: 16447195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
    Dickson RC; Terrault NA; Ishitani M; Reddy KR; Sheiner P; Luketic V; Soldevila-Pico C; Fried M; Jensen D; Brown RS; Horwith G; Brundage R; Lok A
    Liver Transpl; 2006 Jan; 12(1):124-33. PubMed ID: 16382463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment].
    Jiao ZY; Yan LN; Li B; Zeng Y; Wen TF; Lu SC; Zhao JC; Wang WT; Xu MQ; Yang JY; Li ZH; Ma YK; Zhang ZW; Chen ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):804-8. PubMed ID: 18073060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
    Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation.
    Yuefeng M; Weili F; Wenxiang T; Ligang X; Guiling L; Hongwei G; Wencai L; Xiaoguang W; Wei M; Zhongyi F
    Clin Transplant; 2011; 25(4):517-22. PubMed ID: 20560989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.
    Marzano A; Lampertico P; Mazzaferro V; Carenzi S; Vigano M; Romito R; Pulvirenti A; Franchello A; Colombo M; Salizzoni M; Rizzetto M
    Liver Transpl; 2005 May; 11(5):532-8. PubMed ID: 15838891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
    Lu AW; Zheng SS; Wu MP; Shen Y; Yang RW
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):357-61. PubMed ID: 18693169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
    Cholongitas E; Goulis J; Akriviadis E; Papatheodoridis GV
    Liver Transpl; 2011 Oct; 17(10):1176-90. PubMed ID: 21656655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and treatment of hepatitis B recurrence after liver transplantation].
    Zhang XL; Zhu XF; Shi HJ; Cui SZ; Tang YQ; Ba MC; Wang JK; Wang B; Lu Q; Zhao HY; Wu YB; Li ML
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):606-9. PubMed ID: 18646715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
    Gao YJ; Zhang M; Jin B; Meng FP; Ma XM; Liu ZW; Su HB; Zhao JM; Li HW
    J Gastroenterol Hepatol; 2014 Mar; 29(3):554-60. PubMed ID: 24117714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
    Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
    Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection.
    Caccamo L; Agnelli F; Reggiani P; Maggi U; Donato MF; Gatti S; Paone G; Melada E; Rossi G
    Transplantation; 2007 May; 83(10):1341-4. PubMed ID: 17519784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.
    Tanaka T; Benmousa A; Marquez M; Therapondos G; Renner EL; Lilly LB
    Clin Transplant; 2012; 26(5):E561-9. PubMed ID: 23061767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
    Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
    Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
    Neff GW; O'brien CB; Nery J; Shire N; Montalbano M; Ruiz P; Nery C; Safdar K; De Medina M; Tzakis AG; Schiff ER; Madariaga J
    Liver Transpl; 2004 Nov; 10(11):1372-8. PubMed ID: 15497163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of hepatitis B recurrence after liver transplantation.
    Zhu JP; Zhang TL; Li L; Yuan J; Song SB; Xiu DR; Hou KY; Li T; Zhuang H
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):500-3. PubMed ID: 14627508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.